Apotea (PRIVATE.APOTEA)

Overall impact
C (57)

Commentary

Apotea is an average overall performer. With a 'C' rating of 57.3 for overall impact (57th percentile compared to all companies), Apotea ranks 17th out of 62 industry peers, behind Tesco, Woolworths, ICA Gruppen and 13 others, and ahead of Brazilian Distribution, iFresh, Natural Grocers by Vitamin Cottage and 42 others. On top material causes for Apotea's industry (Food & Beverage Retail), Apotea performs well in Reduced Use of tobacco (96.2 score) and Healthy Oceans (81.1) and performs poorly in Child and Maternal Health (32.4 score), Child and Maternal Health (18.5), No Poverty (39.5) and 3 other causes where it received a 'D' or 'F' score.
Impact
Cause PRIVATE.APOTEA
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Founded
2003
Employees
900
Sector
Consumer Staples
Industry
Consumer Staples Distribution & Retail
Sub-industry
Food Retail
SASB industry
Food Retailers & Distributors
Headquarters
Sweden
Share classes
PRIVATE.APOTEA
Description
Operator of an online full-scale pharmacy platform intended to serve people across Sweden. The company's online pharmacy store offers a full range of both prescription and non-prescription drugs for fever and pain, skin and hair, hands and feet, stomach and intestine, mouth and teeth, and vitamins and minerals. This enables customers to meet their pharmaceutical requirements conveniently at lower costs.
Material causes
Ethos considers the following causes material for Apotea, based on its industry sub-industry Food Retail. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.